Correspondence 0001437749-24-023181 from NovaBay Pharmaceuticals, Inc. (NBY) (CIK 0001389545) (NBY)
NovaBay Pharmaceuticals, Inc. (NBY) (CIK 0001389545)
Date: July 22, 2024 · CIK: 0001389545 · Accession: 0001437749-24-023181
AI Filing Summary & Sentiment
File numbers found in text: 333-280423
Letter
nby20240716c_corresp.htm
Ladenburg Thalmann & Co. Inc.
640 Fifth Avenue, 4th Floor
New York, New York 10019
July 22, 2024
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
Office of Life Sciences
100 F Street, N.E.
Washington, DC 20549
Attn:
Jimmy McNamara
Re:
NovaBay Pharmaceuticals, Inc. (the “Company”)
Registration Statement on Form S-1
File No. 333-280423
Ladies and Gentlemen:
Ladenburg Thalmann & Co. Inc. (“Ladenburg”), as representative of the underwriters for the referenced offering, hereby concurs in the request by NovaBay Pharmaceuticals, Inc. that the effective date of the above-referenced registration statement be accelerated to 5:30 p.m. (Eastern Time), or as soon as practicable thereafter, on Tuesday, July 23, 2024, pursuant to Rule 461 under the Securities Act. Ladenburg affirms that it is aware of its obligations under the Securities Act in connection with this offering.
Very truly yours,
Ladenburg Thalmann & Co. Inc.
Show Raw Text
CORRESP 1 filename1.htm nby20240716c_corresp.htm Ladenburg Thalmann & Co. Inc. 640 Fifth Avenue, 4th Floor New York, New York 10019 July 22, 2024 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance Office of Life Sciences 100 F Street, N.E. Washington, DC 20549 Attn: Jimmy McNamara Re: NovaBay Pharmaceuticals, Inc. (the “Company”) Registration Statement on Form S-1 File No. 333-280423 Ladies and Gentlemen: Ladenburg Thalmann & Co. Inc. (“Ladenburg”), as representative of the underwriters for the referenced offering, hereby concurs in the request by NovaBay Pharmaceuticals, Inc. that the effective date of the above-referenced registration statement be accelerated to 5:30 p.m. (Eastern Time), or as soon as practicable thereafter, on Tuesday, July 23, 2024, pursuant to Rule 461 under the Securities Act. Ladenburg affirms that it is aware of its obligations under the Securities Act in connection with this offering. Very truly yours, Ladenburg Thalmann & Co. Inc. By: /s/ Nicholas Stergis Nicholas Stergis Managing Director, Investment Banking